DSM-Firmenich AG Website

DSM-Firmenich AG

ENXTAM-DSFIR

Basic

  • Market Cap

    €29.46B

  • EV

    €31.89B

  • Shares Out

    265.28M

  • Revenue

    €10.63B

  • Employees

    28,685

Margins

  • Gross

    24.57%

  • EBITDA

    3.31%

  • Operating

    -5.27%

  • Pre-Tax

    -6.15%

  • Net

    20.11%

  • FCF

    6.68%

Returns (5Yr Avg)

  • ROA

    7.74%

  • ROTA

    25.66%

  • ROE

    13.19%

  • ROCE

    4.88%

  • ROIC

    4.43%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    €122.51

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    €2,563M

  • Net Debt

    €2,270M

  • Debt/Equity

    0.21

  • EBIT/Interest

    -4.06

Growth (CAGR)

  • Rev 3Yr

    9.45%

  • Rev 5Yr

    2.78%

  • Rev 10Yr

    1.84%

  • Dil EPS 3Yr

    46.78%

  • Dil EPS 5Yr

    8.56%

  • Dil EPS 10Yr

    19.71%

  • Rev Fwd 2Yr

    3.78%

  • EBITDA Fwd 2Yr

    13.01%

  • EPS Fwd 2Yr

    33.2%

  • EPS LT Growth Est

    41.65%

Dividends

  • Yield

    —

  • Payout

    -88.6%

  • DPS

    €2.5

  • DPS Growth 3Yr

    1.37%

  • DPS Growth 5Yr

    1.68%

  • DPS Growth 10Yr

    4.24%

  • DPS Growth Fwd 2Yr

    -0.11%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23

Total Revenues

7,998

8,106

7,269

8,390

10,627

Total Revenues % Chg.

-13.7%

1.4%

-10.3%

15.4%

26.7%

Cost of Goods Sold, Total

5,234

5,330

4,657

5,700

8,016

Gross Profit

2,764

2,776

2,612

2,690

2,611

Selling General & Admin Expenses, Total

1,639

1,622

1,649

1,772

2,535

R&D Expenses

295

398

274

295

652

Other Operating Expenses

23

84

-21

-29

-16

Other Operating Expenses, Total

1,957

2,104

1,902

2,038

3,171

Operating Income

807

672

710

652

-560

Interest Expense, Total

-96

-90

-92

-104

-138

Interest And Investment Income

9

17

3

22

95

Net Interest Expenses

-87

-73

-89

-82

-43

Income (Loss) On Equity Invest.

-9

-64

16

12

-6

Currency Exchange Gains (Loss)

-11

-22

-8

-20

-86

Other Non Operating Income (Expenses)

4

14

-9

-1

-26

EBT, Excl. Unusual Items

704

527

620

561

-721

Merger & Related Restructuring Charges

—

-11

-55

-20

-3

-59

Gain (Loss) On Sale Of Investments

—

63

32

326

-7

-1

Gain (Loss) On Sale Of Assets

7

—

13

31

17

Insurance Settlements

16

29

10

12

53

Legal Settlements

—

—

—

—

8

23

2

—

—

Other Unusual Items

47

7

2

5

57

EBT, Incl. Unusual Items

834

563

953

599

-654

Income Tax Expense

145

106

123

124

-18

Earnings From Continuing Operations

689

457

830

475

-636

Earnings Of Discontinued Operations

—

—

75

51

850

1,240

2,789

Minority Interest

-6

-2

-4

-15

-16

Net Income

758

506

1,676

1,700

2,137

Preferred Dividend and Other Adjustments

8

7

6

6

6

Net Income to Common Incl Extra Items

750

499

1,670

1,694

2,131

Net Income to Common Excl. Extra Items

675

448

820

454

-658

Total Shares Outstanding

172.4

172.2

173

173.1

265.3

Weighted Avg. Shares Outstanding

175.7

171.5

172.6

172.8

233.2

Weighted Avg. Shares Outstanding Dil

176.8

172.4

173.4

173.3

233.4

EPS

4.3

2.9

9.7

9.8

9.1

EPS Diluted

4.2

2.9

9.6

9.8

9.1

EBITDA

1,285

1,209

1,305

1,234

352

Effective Tax Rate

17.4%

18.8%

12.9%

20.7%

2.8%